JAMA pediatrics. 2025 Jun 16. doi: 10.1001/jamapediatrics.2025.1552 Q118.02025
Will Nirsevimab Reduce the Burden on Public Health Care?-Reply
Nirsevimab能否减轻公共医疗卫生系统的负担——关于“减少呼吸道合胞病毒感染的经济负担”的回复 翻译改进
作者单位 +展开
作者单位
DOI: 10.1001/jamapediatrics.2025.1552 PMID: 40522642
摘要 中英对照阅读
Keywords：nirsevimab; public health care
相关内容
-
Will Nirsevimab Reduce the Burden on Public Health Care?
尼塞维单抗能减轻公共医疗负担吗？
JAMA pediatrics. 2025 Jun 16.
-
Nirsevimab-a breakthrough in respiratory syncytial virus bronchiolitis
尼塞韦单抗——防治呼吸道合胞病毒性毛细支气管炎的突破进展
The Lancet. Child & adolescent health. 2024 Oct;8(10):708-709.
-
Effectiveness of Nirsevimab Immunoprophylaxis Against Respiratory Syncytial Virus-related Outcomes in Hospital Care Settings: A Seasonal Cohort Study of Infants in Catalonia (Spain)
尼塞维单抗对住院婴儿呼吸道合胞病毒相关结局的预防效果：一项在西班牙加泰罗尼亚地区开展的季节性队列研究
The Pediatric infectious disease journal. 2025 Jan 17.
-
Nirsevimab: A Review
尼塞西单抗：综述
Pediatric allergy, immunology, and pulmonology. 2024 Mar;37(1):3-6.
-
Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024)
尼塞维单抗免疫对儿童住院率影响的系统评价和Meta分析(2024)
Vaccines. 2024 Jun 8;12(6):640.
-
The impact of antipsychotic polytherapy costs in the public health care in Sao Paulo, Brazil
巴西圣保罗州公共卫生体系中抗精神病药物联合使用的影响及费用支出
PloS one. 2015 Apr 8;10(4):e0124791.
-
PUBLIC medical care
公共医疗护理
New York state journal of medicine. 1947 May 1;47(9):1024.
-
[Current forum. 40 years German Central Unit for Public Health Care--the German Central Unit for Public Health Care was discontinued June 1996]
当前论坛。德国中央公共卫生局40年-德国中央公共卫生局于1996年6月停业
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). 1996 Dec;58(12):685-90.
